Who is sponsoring NCT06209333?

NCT06209333 is sponsored by Hacettepe University.

What drugs are being tested in NCT06209333?

Interventions in NCT06209333: Standard Patient Education, bladder training, pelvic floor exercise.

What condition does NCT06209333 study?

NCT06209333 studies Overactive Bladder Syndrome (OABS).

Is NCT06209333 still recruiting?

NCT06209333 is currently status unknown. Last updated 17 January 2024.

Last reviewed 2024-01-17 · How we verify

NCT06209333: OABS/BT/PFET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS

Status unknown NA Last updated 17 January 2024

What this trial tests

NA trial testing Standard Patient Education in Overactive Bladder Syndrome (OABS) in 50 participants. Status unknown.

Timeline

15 October 2023

Primary endpoint
15 October 2024

15 October 2024

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	15 October 2023
Primary completion	15 October 2024
Estimated completion	15 October 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Standard Patient Education
bladder training
pelvic floor exercise

Conditions studied

Overactive Bladder Syndrome (OABS) — all drugs for Overactive Bladder Syndrome (OABS) →

Sponsor

Hacettepe University

Who can join

18 and older, any sex, with Overactive Bladder Syndrome (OABS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to examine the effects of bladder training and pelvic floor exercise training programs given in addition to Botulinum Toxin-A (BTx-A) application on urinary symptoms and quality of life in patients with Overactive Bladder Syndrome (AAMS) who do not respond to conservative treatments. Individuals who meet the criteria for inclusion in the study and agree to participate in the study will be divided into 2 separate research branches.The patients to be included in the study will be divided into two groups as "Group 1=Botox + physiotherapy " or "Group 2=Botox group ". In addition to the BTx-A application, bladder training and pelvic floor exercise training will be applied to patients in the first group, while standard patient training will be provided to patients in the second group. Severity of urinary symptoms, quality of life and subjective perception of improvement Before BTx-A application, 2 weeks and 12 weeks after BTX-A application, International Incontinence Consultation Questionnaire - Women's Lower Urinary Tract Symptoms (ICIQ-FLUTS), 1-hour ped test, International Incontinence Consultation- Lower Urinary Tract Symptoms Quality of Life Scale (ICIQ-LUTS) and Global Perception of Improvement will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Standard Patient Education

Trials testing the same drug.

NCT04944186 — Effect of Structured Pressure Injury Patient Education · NA · completed

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06209333 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 17 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06209333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing